(Q52033145)

English

Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type.

scientific article published in June 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

cerebrospinal fluid

0 references

1 reference

based on heuristic

inferred from title

author name string

Engelborghs S

1

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

De Brabander M

2

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

De Crée J

3

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

D'Hooge R

4

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

Geerts H

5

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

Verhaegen H

6

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

De Deyn PP

7

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

Neurochemistry International

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

34

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

6

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

523-530

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced natural killer cell activity in patients with dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum interleukin-2 levels in patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute-phase proteins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune system associated antigens expressed by cells of the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of interleukin-1β and β2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased levels of interleukin-1beta and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glial cytokines in Alzheimer's disease: Review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Approach to define “normal aging” in man. Immune function, serum lipids, lipoproteins and neopterin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900031-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0197-0186(99)00031-5

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10402228

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52033145&oldid=2097266689"